Furthermore, discordances in ER/PR/HER2 test results between tumor core needle biopsy taken at the time of diagnosis and tumor resection material are low, also in patients receiving any form of neoadjuvant therapy [31]. The gene discussed is PGR; the disease is neoplasm.